Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
Journal of Gastrointestinal Oncology|September 17, 2021
Influence of first line chemotherapy strategy depending on primary tumor location in metastatic colorectal cancerZoé Tharin, Julie Blanc, Ikram Charifi Alaoui, et al.
Cancer Immunology, Immunotherapy : CII|March 16, 2022
Targeting PD-L1 and TIGIT could restore intratumoral CD8 T cell function in human colorectal cancerMarion Thibaudin, Emeric Limagne, Léa Hampe, et al.
Molecular and Clinical Oncology|October 11, 2021
Utility of exome sequencing in routine care for metastatic colorectal cancerMelchior De Giraud D'Agay, Loïck Galland, Zoe Tharin, et al.
World Journal of Gastroenterology|March 4, 2014
Prognostic value of chemotherapy-induced hematological toxicity in metastatic colorectal cancer patientsLaurie Rambach, Aurelie Bertaut, Julie Vincent, et al.
World Journal of Gastroenterology|February 27, 2015
FOLFIRI plus bevacizumab as a second-line therapy for metastatic intrahepatic cholangiocarcinomaJean-Florian Guion-Dusserre, Veronique Lorgis, Julie Vincent, et al.
Anticancer Research|October 3, 2018
Bevacizumab-based Chemotherapy for Poorly-differentiated Neuroendocrine TumorsThomas Collot, Jean-David Fumet, Quentin Klopfenstein, et al.
European Journal of Cancer (Oxford, England : 1990)|September 25, 2020
Immunological features of coronavirus disease 2019 in patients with cancerMarion Thibaudin, Jean-David Fumet, Marjorie Bon, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 9, 2014
Epidemiology and prognosis of synchronous and metachronous colon cancer metastases: a French population-based studyFrancois Ghiringhelli, Audrey Hennequin, Antoine Drouillard, et al.
Anti-Cancer Drugs|March 11, 2010
Raltitrexed and oxaliplatin hepatic arterial infusion for advanced colorectal cancer: a retrospective studyCedric Khouri, Boris Guiu, Jean Pierre Cercueil, et al.
World Journal of Gastrointestinal Oncology|August 23, 2019
Safety and efficacy of a docetaxel-5FU-oxaliplatin regimen with or without trastuzumab in neoadjuvant treatment of localized gastric or gastroesophageal junction cancer: A retrospective studyValeria Basso, David Orry, Jean Fraisse, et al.
Pageof 10